跳至主要内容
临床试验/JPRN-UMIN000028487
JPRN-UMIN000028487已完成未知

The usefulness of serum APM2 as a predictable marker for the response to platinum based antineoplastic drugs. - Serum APM2 as a predictable marker for platinum antineoplastic drug effects

Division of Gastroenterology and Hepatology, Graduate School of Medical and Dental Sciences, Niigata University0 个研究点目标入组 100 人开始时间: 2017年8月2日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
100